-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Fzx4hwXdQ3wjf/yxqlNaHWjBXQo0skHuzH9bV7sZWVom091ZwoBMkekZtw9vedte 0y4eRKiItINcXfsN4pDZMg== 0000912057-01-007681.txt : 20010319 0000912057-01-007681.hdr.sgml : 20010319 ACCESSION NUMBER: 0000912057-01-007681 CONFORMED SUBMISSION TYPE: 424B3 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20010316 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INHALE THERAPEUTIC SYSTEMS INC CENTRAL INDEX KEY: 0000906709 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943134940 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: SEC FILE NUMBER: 333-53678 FILM NUMBER: 1570520 BUSINESS ADDRESS: STREET 1: 150 INDUSTRIAL RD. CITY: SAN CARLOS STATE: CA ZIP: 94070 BUSINESS PHONE: 6506313100 MAIL ADDRESS: STREET 1: 150 INDUSTRIAL ROAD CITY: SAN CARLOS STATE: CA ZIP: 94070 FORMER COMPANY: FORMER CONFORMED NAME: INHALE THERAPEUTIC SYSTEMS DATE OF NAME CHANGE: 19940303 424B3 1 a2041964z424b3.txt 424B3 Filed Pursuant to Rule 424(b)(3) and (c) File No. 333-53678 PROSPECTUS SUPPLEMENT NO. 1 INHALE THERAPEUTIC SYSTEMS, INC. $230,000,000 OF 3.5% CONVERTIBLE SUBORDINATED NOTES DUE OCTOBER 17, 2007 AND 4,558,065 SHARES OF COMMON STOCK ISSUABLE UPON CONVERSION OF THE NOTES This prospectus supplement supplements the prospectus dated February 2, 2001 of Inhale Therapeutic Systems, Inc. relating to the public offering and sale by selling security holders described below. This prospectus supplement contains information on ownership of principal amount of notes beneficially owned and offered and shares of our common stock issuable upon conversion of the notes. This prospectus supplement should be read in conjunction with the prospectus, and this prospectus supplement is qualified by reference to the prospectus, except to the extent that the information provided by this prospectus supplement supersedes the information contained in the prospectus. SEE "RISK FACTORS" BEGINNING ON PAGE 5 OF THE PROSPECTUS TO READ ABOUT FACTORS YOU SHOULD CONSIDER BEFORE BUYING THE NOTES OR OUR COMMON STOCK. ------------------------------------------------ Neither the Securities and Exchange Commission nor any other regulatory body has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense. The table and related notes, and the paragraphs immediately following the table and related notes, appearing in the prospectus under the heading "Selling Security Holders" is amended by the addition of the following table and related notes, and the following paragraph immediately following the table and related notes:
- ---------------------------------------------- --------------------- ------------------ ------------ -------------------- NAME PRINCIPAL AMOUNT OF COMMON STOCK COMMON COMMON STOCK OWNED NOTES BENEFICIALLY ISSUABLE UPON STOCK AFTER COMPLETION OWNED AND OFFERED CONVERSION OF OFFERED OF THE OFFERING (1)(2) THE NOTES (2) - ---------------------------------------------- --------------------- ------------------ ------------ -------------------- Allstate Life Insurance Company 200,000 3,963 3,963 -- - ---------------------------------------------- --------------------- ------------------ ------------ -------------------- City of New Orleans 174,000 3,448 3,448 -- - ---------------------------------------------- --------------------- ------------------ ------------ -------------------- JMG Capital Partners, LP 2,000,000 39,635 39,635 -- - ---------------------------------------------- --------------------- ------------------ ------------ -------------------- JMG Triton Offshore Fund, Ltd. 6,500,000 128,814 128,814 -- - ---------------------------------------------- --------------------- ------------------ ------------ -------------------- KBC Financial Products USA 2,500,000 49,544 49,544 -- - ---------------------------------------------- --------------------- ------------------ ------------ -------------------- Merrill Lynch Pierce Fenner & Smith Inc. 5,690,000 112,762 112,762 -- - ---------------------------------------------- --------------------- ------------------ ------------ -------------------- Onyx Fund Holding, LDC 3,000,000 59,453 59,453 -- - ---------------------------------------------- --------------------- ------------------ ------------ -------------------- Pro Mutual 651,000 12,901 12,901 -- - ---------------------------------------------- --------------------- ------------------ ------------ -------------------- Raytheon Master Pension Trust 470,000 9,314 9,314 -- - ---------------------------------------------- --------------------- ------------------ ------------ -------------------- Shell Pension Trust 376,000 7,451 7,451 -- - ---------------------------------------------- --------------------- ------------------ ------------ --------------------
------------------ (1) Amounts indicated may be in excess of the total amount registered due to sales or transfers exempt from the registration requirements of the Securities Act since the date upon which the selling holders provided to us in the information regarding their notes. (2) Amounts listed include additional amounts now being registered by the selling holder for notes beneficially owned and offered and common stock issuable upon conversion of the notes that were already included in the prospectus dated February 2, 2001. Additional information regarding selling holders will be provided by amendment or supplement to this prospectus. With the exception of Merrill Lynch Pierce Fenner & Smith Inc. and Deutsche Bank Securities Inc., none of the selling holders nor any of their affiliates, officers, directors or principal equity holders has held any position or office or has had any material relationship with us within the past three years, although the selling holders may hold additional securities of Inhale. Merrill Lynch Pierce Fenner & Smith Inc. and Deutsche Bank Securities Inc. were initial purchasers of the notes. The selling holders purchased the notes in private transactions on or after October 27, 2000. All of the notes were "restricted securities" under the Securities Act prior to this registration. Information concerning the selling holders may change from time to time and any changed information will be set forth in supplements to this prospectus if and when necessary. In addition, the conversion rate and therefore, the number of shares of common stock issuable upon conversion of the notes, is subject to adjustment under certain circumstances. Accordingly, the aggregate principal amount of notes and the number of shares of common stock into which the notes are convertible may increase or decrease. The date of this prospectus supplement is March 16, 2001. -----END PRIVACY-ENHANCED MESSAGE-----